Intercept Pharmaceuticals | Ativo Circulante



Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amarin USD 628.33M 21.52M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Galectin Therapeutics USD 27.29M 1.83M 2024-06
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12


Intercept Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.